PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
4.46M / 3.59M (Avg.)
-1.65 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
0.64
P/E 50-75% of CRN.AX's 1.14. Mohnish Pabrai would examine if this pricing gap presents opportunity.
0.35
P/S less than half of CRN.AX's 1.29. Joel Greenblatt would verify if margins support this discount.
-3.68
Negative equity while CRN.AX shows P/B of 1.06. Joel Greenblatt would examine balance sheet repair potential.
2.48
P/FCF 50-75% of CRN.AX's 4.48. Bruce Berkowitz would examine if capital allocation explains the gap.
2.22
P/OCF 50-75% of CRN.AX's 3.83. Bruce Berkowitz would examine if working capital management explains the gap.
-3.68
Negative fair value while CRN.AX shows ratio of 1.06. Joel Greenblatt would examine valuation model differences.
38.83%
Earnings yield exceeding 1.5x CRN.AX's 22.00%. David Dodd would verify if earnings quality justifies this premium.
40.32%
FCF yield exceeding 1.5x CRN.AX's 22.33%. David Dodd would verify if cash flow quality justifies this premium.